Stay updated with breaking news from Pascal Deschatelets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Wedbush increased their Q3 2023 earnings estimates for shares of Apellis Pharmaceuticals in a note issued to investors on Thursday, July 20th. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of ($1.06) for the quarter, up from their […]
China Universal Asset Management Co. Ltd. grew its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 110.7% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,366 shares of the company’s stock after buying an additional 1,243 shares during the period. China Universal […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) insider Pascal Deschatelets sold 12,000 shares of Apellis Pharmaceuticals stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $84.55, for a total value of $1,014,600.00. Following the completion of the transaction, the insider now owns 1,046,813 shares in the […]
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $94.75 and last traded at $94.12, with a volume of 168048 shares trading hands. The stock had previously closed at $93.31. Wall Street Analysts Forecast Growth A number of […]
Moore Capital Management LP trimmed its holdings in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) by 94.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,000 shares of the company’s stock after selling 169,958 shares during the quarter. Moore Capital Management […]